Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Eli Lilly & Co (LLY)  
$837.29 5.53 (0.66%) as of 4:30 Thu 6/6


Download
   
Exchange: New York Stock Exchange
Security Type: Common
Shares Out: 956,580,000
Market Cap: 800.93(B)
Last Volume: 2,108,588 Avg Vol: 3,278,293
52 Week Range: $434.7 - $815.06
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Major

Member Indexes:
    S&P COMPOSITE 1500     NYSE COMPOSITE
    S&P 500

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  720
Guru Rank Value     : 1.4
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Eli Lilly and Company discovers, develops, manufactures, and markets products in a single business segment: human pharmaceutical products. Co.'s products include: diabetes products, oncology products, immunology products, neuroscience products, and other therapies. Co.'s diabetes products include: Baqsimi®, Basaglar®, Humalog®, Humulin®, Jardiance®, Lyumjev®, Trajenta®, and Trulicity®. Co.'s oncology products include: Alimta®, Cyramza®, Erbitux®, Retevmo®, Tyvyt®, and Verzenio®. Co.'s immunology products include: Olumiant® and Taltz®. Co.'s neuroscience products include: Cymbalta®, Emgality®, Reyvow®, and Zyprexa®. Co.'s other therapies include: Bamlanivimab, Cialis®, and Forteo®.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 656
Total Buy Value $0 $0 $0 $199,549
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 698,556 1,568,556 3,207,712 6,168,224
Total Sell Value $569,078,450 $1,176,763,830 $2,147,483,647 $2,147,483,647
Total People Sold 3 3 4 6
Total Sell Transactions 11 23 50 90
End Date 2024-03-08 2023-12-06 2023-06-07 2022-06-07

   
Records found: 3315
  Page 17 of 133  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Norton Johna Senior VP, Global Quality   •       –      –    2022-02-09 4 A $243.27 $801,331 D/D 3,294 30,240     -
   Ashkenazi Anat SVP & CFO   •       –      –    2022-02-09 4 A $243.27 $1,399,289 D/D 5,752 31,427     -
   Weems Alonzo SVP, ERM & CECO   •       –      –    2022-02-09 4 A $243.27 $907,640 D/D 3,731 8,792     -
   Mason Michael B Sr. VP & Pres., Lilly Diabetes   •       –      –    2022-02-09 4 A $243.27 $635,421 D/D 2,612 27,506     -
   Skovronsky Daniel SVP, CS&MO & Pres. LRL   •       –      –    2022-02-09 4 A $243.27 $5,493,280 D/D 22,581 78,559     -
   Zakrowski Donald A Chief Accounting Officer   •       –      –    2022-02-09 4 A $243.27 $716,917 D/D 2,947 8,934     -
   Skovronsky Daniel SVP, CS&MO & Pres. LRL   •       –      –    2022-02-01 4 D $245.39 $2,070,355 D/D (8,437) 55,978     -
   Skovronsky Daniel SVP, CS&MO & Pres. LRL   •       –      –    2022-02-01 4 OE $0.00 $0 D/D 18,735 64,415     -
   White Anne E. SVP & Pres-Lilly Neuroscience   •       –      –    2022-02-01 4 D $245.39 $1,031,620 D/D (4,204) 39,004     -
   White Anne E. SVP & Pres-Lilly Neuroscience   •       –      –    2022-02-01 4 OE $0.00 $0 D/D 9,368 43,208     -
   Ricks David A President & CEO   •       •      –    2022-02-01 4 D $245.39 $6,176,466 D/D (25,170) 399,779     -
   Ricks David A President & CEO   •       •      –    2022-02-01 4 OE $0.00 $0 D/D 56,205 424,949     -
   Pusey Leigh Ann SVP, Corp. Affairs & Comm.   •       –      –    2022-02-01 4 D $245.39 $493,234 D/D (2,010) 20,935     -
   Pusey Leigh Ann SVP, Corp. Affairs & Comm.   •       –      –    2022-02-01 4 OE $0.00 $0 D/D 4,416 22,945     -
   Fry Stephen F SVP, HR & Diversity   •       –      –    2022-02-01 4 D $245.39 $1,117,506 D/D (4,554) 140,292     -
   Fry Stephen F SVP, HR & Diversity   •       –      –    2022-02-01 4 OE $0.00 $0 D/D 10,170 144,846     -
   Norton Johna Senior VP, Global Quality   •       –      –    2022-02-01 4 D $245.39 $292,996 D/D (1,194) 26,946     -
   Norton Johna Senior VP, Global Quality   •       –      –    2022-02-01 4 OE $0.00 $0 D/D 2,676 28,140     -
   Johnson Kimberly H Director   –       •      –    2022-01-18 4 A $247.07 $9,636 D/D 39 1,093     -
   Alvarez Ralph Director   –       •      –    2022-01-18 4 A $247.07 $11,365 D/D 46 51,142     -
   Luciano Juan R Director   –       •      –    2022-01-18 4 A $247.07 $12,601 D/D 51 13,538     -
   Greene Gabrielle E Director   –       •      –    2022-01-18 4 A $247.07 $9,883 D/D 40 720     -
   Fyrwald J Erik Director   –       •      –    2022-01-18 4 A $247.07 $9,883 D/D 40 68,842     -
   Lilly Endowment Inc 10% Owner   –       –       •   2021-12-30 4 S $279.55 $1,010,276 D/D (3,614) 107,463,810 -3%     
   Lilly Endowment Inc 10% Owner   –       –       •   2021-12-27 4 S $279.53 $997,925 D/D (3,570) 107,467,424 -5%     
  3315 Records found
  Previous  10  11  12  13  14  15  16  17  18  19  Next   
  Page 17 of 133
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us